Analgesics (Pharmacies) - Norway | Statista Market Forecast

Revenue in the Analgesics market is projected to reach US$34.45m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.94%, resulting in a market volume of US$39.82m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$6.25 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Norway has been experiencing steady growth in recent years, driven by several key factors.

Customer preferences: Norwegian consumers have shown a strong preference for over-the-counter analgesics purchased from pharmacies. This preference can be attributed to the trust and reliability associated with pharmacies, as well as the convenience of being able to seek advice from a pharmacist. Additionally, the high quality and safety standards of analgesics sold in pharmacies provide reassurance to consumers.

Trends in the market: One notable trend in the Analgesics (Pharmacies) market in Norway is the increasing demand for natural and herbal remedies. This trend is in line with the global shift towards more natural and holistic approaches to healthcare. Consumers are seeking analgesics that are perceived to be more gentle on the body and have fewer side effects. As a result, pharmacies in Norway have been expanding their range of natural and herbal analgesics to cater to this growing demand. Another trend in the market is the rising popularity of online pharmacies. Norwegian consumers are increasingly turning to online platforms to purchase analgesics due to the convenience and competitive pricing offered. Online pharmacies provide a wide range of products, allowing consumers to compare and choose the most suitable analgesic for their needs. The ease of online ordering and home delivery services also contribute to the growing popularity of online pharmacies.

Local special circumstances: One unique aspect of the Norwegian market is the strong emphasis on sustainability and environmental consciousness. Norwegian consumers are known for their commitment to eco-friendly practices and are actively seeking products that align with their values. This has led to an increased demand for analgesics that are produced using sustainable and environmentally-friendly methods. Pharmacies in Norway have responded to this demand by stocking analgesics that are certified organic, cruelty-free, and produced using renewable resources.

Underlying macroeconomic factors: The stable and prosperous economy of Norway has played a significant role in the growth of the Analgesics (Pharmacies) market. With a high standard of living and disposable income, Norwegian consumers have the means to prioritize their health and well-being. This has resulted in increased spending on analgesics and other healthcare products. Furthermore, the aging population in Norway has contributed to the growth of the market. As the population ages, the demand for analgesics to manage chronic pain and age-related ailments has increased. Pharmacies have capitalized on this trend by offering a wide range of analgesics specifically targeted towards the elderly population. In conclusion, the Analgesics (Pharmacies) market in Norway is developing in response to customer preferences for reliable and convenient access to analgesics. The market is also influenced by global trends towards natural and herbal remedies, as well as the rise of online pharmacies. Local special circumstances, such as the emphasis on sustainability, further shape the market. The stable economy and aging population in Norway are underlying macroeconomic factors that contribute to the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.